Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;14(1):9-14.

Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: A RCT

Ahmad Mahran  1 , Ayman Abdelmeged  1 , Hossam Shawki  1 , Abdelrazek Moheyelden  1 , Asmaa Mohamed Ahmed  2
Affiliations

Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: A RCT

Ahmad Mahran et al. Int J Reprod Biomed. 2016 Jan.

Abstract

Background: Clomiphene citrate (CC) is the first line agent used for ovulation induction in patients with polycystic ovarian syndrome (PCOS). However, there is marked discrepancy between the ovulation and pregnancy rates achieved, which may be attributed to the undesirable effect of CC on cervical mucus and endometrium.

Objective: The aim of this study was to evaluate the effect of Isosorbid monoitrate (ISMN) as nitric oxide (NO) donors on the ovulation and pregnancy rates in an ovulatory women with PCOS treated with CC.

Materials and methods: Ninety patients with PCOS were randomly allocated into three groups. Patients in group A) were treated with 100 mg CC for five days starting from the fifth day of the cycle. Patients in group B) and C) received 10 mg and 20 mg of ISMN respectively in addition to CC, applied vaginally till the diagnosis of ovulation.

Results: There was a significant increase in the ovulation and pregnancy rates in the patients treated with CC+ISMN as compared with patients treated with CC alone (p< 0.001).

Conclusion: Concomitant use of NO with CC seems to improve the ovulation and pregnancy rates in the patients with PCOS with no significant increase in side effects as compared with CC alone.

Keywords: Clomiphene citrate; Nitric oxide donors; Polycystic ovary syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest in this paper.

Figures

Figure 1
Figure 1
Consort flow diagram
See this image and copyright information in PMC

References

    1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endorcinol Metab. 2004;89:2745–2749. - PubMed
    1. Thessaloniki ESHRE/ASRM-Sponsered PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008;23:462–477. - PubMed
    1. De Pace V, Chiossi G, Facchinetti F. Clinical use of nitric oxide donors and L-arginine in obstetrics. J Matern Fetal Neonat Med. 2007;20:569–579. - PubMed
    1. Tsukimori K, Komatsu H, Fukushima K, Kaku T, Nakano H, Wake N. Inhibition of nitric oxide synthetase at mid-gestation in rats is associated with increases in arterial pressure, serum tumour necrosis factor-alpha, and placental apoptosis. Am J Hypertens. 2008;21:477–481. - PubMed
    1. Agarwal A, Gupta S, Sharma Y. Role of oxidative stress in female reproduction. Reprod Biol Endocrin. 2005;3:28. - PMC - PubMed

LinkOut - more resources